Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer

Research output: Contribution to journalArticle

138 Scopus citations
Original languageEnglish (US)
Pages (from-to)911-922
Number of pages12
JournalBritish Journal of Cancer
Volume99
Issue number6
DOIs
Publication statusPublished - Sep 16 2008

    Fingerprint

Keywords

  • EGFR
  • Erlotinib
  • Inhibitor
  • Lung cancer
  • MET
  • Resistance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. / Tang, Z.; Du, R.; Jiang, S.; Wu, C.; Barkauskas, D. S.; Richey, J.; Molter, J.; Lam, M.; Flask, C.; Gerson, S.; Dowlati, A.; Liu, L.; Lee, Z.; Halmos, B.; Wang, Y.; Kern, J. A.; Ma, P. C.

In: British Journal of Cancer, Vol. 99, No. 6, 16.09.2008, p. 911-922.

Research output: Contribution to journalArticle